Home › Funds › Nationwide › Nationwide Bailard Cognitive Value Fund
Fund family: Nationwide · Filed by NATIONWIDE MUTUAL FUNDS (CIK 1048702) · SEC series S000041092
Share classes and tickers: NWHDX (C000127572), NWHEX (C000127573), NWHFX (C000127574), NWHGX (C000127575), NWHHX (C000127576)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,327 with, 13 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 10 FOR, 1 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Nationwide’s manager page (159,461 ballot items across 59 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Nationwide | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 85.7% | 2,272 | 94.0% | 138,376 |
| Backed environmental and social shareholder proposals at US companies | n/a | 2 | 7.3% | 1,864 |
Each ballot item this fund voted is set against the votes of the other Nationwide funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Nationwide funds on 160 items (9.9% of the 1,623 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Nationwide funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Taylor Morrison Home Corporation | 2026-05-21 | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | Against | FOR — 8 of 8 Nationwide funds | Against | — |
| ePlus inc. | 2025-09-16 | To approve, on an advisory basis, our named executive officer compensation. | Against | FOR — 7 of 7 Nationwide funds | Against | Approved, 89.6% support |
| Sanmina Corporation | 2026-03-09 | Shareholder To consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. | For | AGAINST — 6 of 6 Nationwide funds | Against | Failed (calculated), 11.9% support |
| Sanmina Corporation | 2026-03-09 | To elect eight directors of Sanmina Corporation: Mythili Sankaran | Against | FOR — 6 of 6 Nationwide funds | Against | Passed (calculated), 56.9% support |
| Heritage Insurance Holdings, Inc. | 2026-06-10 | Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive Officers | Against | FOR — 6 of 6 Nationwide funds | Against | Passed (calculated), 93.9% support |
| Winmark Corporation | 2026-04-22 | Advisory vote to approve executive compensation. | Against | FOR — 6 of 6 Nationwide funds | Against | Passed (calculated), 96.7% support |
| Citi Trends, Inc. | 2026-06-10 | An advisory vote to approve, on a non-binding basis, the compensation of our named executive officers as set forth in the proxy statement. | Against | FOR — 6 of 6 Nationwide funds | Against | Approved, 99.1% support |
| Designer Brands Inc. | 2026-06-17 | Advisory vote to approve the compensation paid to our named executive officers in the fiscal year ended January 31, 2026. | Against | FOR — 6 of 6 Nationwide funds | Against | Approved, 97.4% support |
| Ryder System, Inc. | 2026-05-01 | Shareholder To vote, on an advisory basis, on a shareholder proposal regarding an independent board chair. | For | AGAINST — 5 of 5 Nationwide funds | Against | Failed (calculated), 21.1% support |
| Mirum Pharmaceuticals, Inc. | 2026-06-15 | To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSci | Withhold | FOR — 5 of 5 Nationwide funds | Against | Elected, 85.3% support |
| Mirum Pharmaceuticals, Inc. | 2026-06-15 | To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: William Fairey | Withhold | FOR — 5 of 5 Nationwide funds | Against | Elected, 86.8% support |
| Associated Banc-Corp | 2026-04-28 | The ratification of the selection of KPMG LLP as the independent registered public accounting firm for Associated Banc-Corp for the year ending December 31, 2026. | Against | FOR — 5 of 5 Nationwide funds | Against | Approved, 97.8% support |
| Bread Financial Holdings, Inc. | 2026-05-19 | ADVISORY VOTE ON EXECUTIVE COMPENSATION | Against | FOR — 5 of 5 Nationwide funds | Against | Approved, 92.0% support |
| Callaway Golf Company | 2026-05-21 | To approve, on an advisory basis, the compensation of the Company's named executive officers | Against | FOR — 5 of 5 Nationwide funds | Against | Approved, 93.9% support |
| Tompkins Financial Corporation | 2026-05-19 | Advisory approval of the compensation paid to the Company's Named Executive Officers. | Against | FOR — 5 of 5 Nationwide funds | Against | Approved, 97.7% support |
| Capital City Bank Group, Inc. | 2026-04-21 | To consider and approve, on a non-binding advisory basis, the compensation of our named executive officers. | Against | FOR — 5 of 5 Nationwide funds | Against | Passed (calculated), 98.5% support |
| American Integrity Insurance Group, Inc. | 2026-06-11 | To approve, on an advisory basis, the compensation of the Company's named executive officers; and | Against | FOR — 5 of 5 Nationwide funds | Against | Passed (calculated), 97.9% support |
| Greenlight Capital Re, Ltd. | 2025-07-29 | To consider and cast a non-binding advisory vote on a resolution approving the compensation of the Company's named executive officers as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission. | Against | FOR — 5 of 5 Nationwide funds | Against | Passed (calculated), 91.8% support |
| Oil States International, Inc. | 2026-05-12 | TO APPROVE, ON AN ADVISORY BASIS, THE COMPANY'S EXECUTIVE COMPENSATION. | Against | FOR — 5 of 5 Nationwide funds | Against | Passed (calculated), 93.7% support |
| Amneal Pharmaceuticals, Inc. | 2026-05-06 | Election of Directors: Deb Autor | Against | FOR — 4 of 4 Nationwide funds | Against | Elected, 92.3% support |
| Amneal Pharmaceuticals, Inc. | 2026-05-06 | Election of Directors: J. Kevin Buchi | Against | FOR — 4 of 4 Nationwide funds | Against | Elected, 90.9% support |
| Amneal Pharmaceuticals, Inc. | 2026-05-06 | Election of Directors: Jeff George | Against | FOR — 4 of 4 Nationwide funds | Against | Elected, 92.3% support |
| Amneal Pharmaceuticals, Inc. | 2026-05-06 | Election of Directors: John Kiely | Against | FOR — 4 of 4 Nationwide funds | Against | Elected, 88.3% support |
| Amneal Pharmaceuticals, Inc. | 2026-05-06 | Election of Directors: Paul Meister | Against | FOR — 4 of 4 Nationwide funds | Against | Elected, 87.5% support |
| Amneal Pharmaceuticals, Inc. | 2026-05-06 | Election of Directors: Shlomo Yanai | Against | FOR — 4 of 4 Nationwide funds | Against | Elected, 92.3% support |
| Company | Meeting | Item | This fund | Most Nationwide funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| OUTFRONT Media Inc. | 2026-06-03 | Election of Director Nominees: Angela Courtin | Against | FOR — 4 of 4 Nationwide funds | Against | Passed (calculated), 76.3% support |
| OUTFRONT Media Inc. | 2026-06-03 | Election of Director Nominees: Susan M. Tolson | Against | FOR — 4 of 4 Nationwide funds | Against | Passed (calculated), 66.4% support |
| CRISPR Therapeutics AG | 2026-06-04 | Approval of the CRISPR Therapeutics AG 2026 Stock Option and Incentive Plan. | Against | FOR — 4 of 4 Nationwide funds | Against | Approved, 88.1% support |
| CRISPR Therapeutics AG | 2026-06-04 | Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027. | Against | FOR — 4 of 4 Nationwide funds | Against | — |
| CRISPR Therapeutics AG | 2026-06-04 | Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026. | Against | FOR — 4 of 4 Nationwide funds | Against | — |
| Boot Barn Holdings, Inc. | 2025-08-27 | Ratification of Deloitte & Touche LLP as the independent auditor for the fiscal year ending March 28, 2026. | Against | FOR — 4 of 4 Nationwide funds | Against | Approved, 97.5% support |
| MaxLinear, Inc. | 2026-05-20 | To approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2025, as set forth in the proxy statement. | Against | FOR — 4 of 4 Nationwide funds | Against | Approved, 85.0% support |
| Excelerate Energy, Inc. | 2026-06-04 | To elect the seven director nominees named in the proxy statement as directors of the Company, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification: Deborah L. Bye | Withhold | FOR — 4 of 4 Nationwide funds | Against | Elected, 99.7% support |
| Excelerate Energy, Inc. | 2026-06-04 | To elect the seven director nominees named in the proxy statement as directors of the Company, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification: Paul T. Hanrah | Withhold | FOR — 4 of 4 Nationwide funds | Against | Elected, 99.3% support |
| NMI Holdings, Inc. | 2026-05-14 | Advisory approval of NMI Holdings, Inc.'s executive compensation. | Against | FOR — 4 of 4 Nationwide funds | Against | Approved, 92.5% support |
| SkyWest, Inc. | 2026-05-05 | Shareholder A shareholder proposal regarding collective bargaining policy. | For | AGAINST — 4 of 4 Nationwide funds | Against | — |
| IDEAYA Biosciences, Inc. | 2026-06-16 | To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: M. Garret Hampton, Ph.D. | Withhold | FOR — 4 of 4 Nationwide funds | Against | Passed (calculated), 77.7% support |
| Ambarella, Inc. | 2026-06-26 | To approve on a non-binding, advisory basis, the compensation of our named executive officers. | Against | FOR — 4 of 4 Nationwide funds | Against | — |
| Interface, Inc. | 2026-05-19 | Approval, on an advisory basis, of executive compensation. | Against | FOR — 4 of 4 Nationwide funds | Against | Passed (calculated), 97.7% support |
| BioCryst Pharmaceuticals, Inc. | 2026-06-11 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for 2026. | Against | FOR — 4 of 4 Nationwide funds | Against | Approved, 96.7% support |
| Veracyte, Inc. | 2026-06-10 | The approval of an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan. | Against | FOR — 4 of 4 Nationwide funds | Against | Passed (calculated), 71.2% support |
| Harmony Biosciences Holdings, Inc. | 2026-05-14 | Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC's compensation disclosure rules. | Against | FOR — 4 of 4 Nationwide funds | Against | Approved, 71.8% support |
| Harmony Biosciences Holdings, Inc. | 2026-05-14 | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. | Against | FOR — 4 of 4 Nationwide funds | Against | Approved, 98.3% support |
| Proto Labs, Inc. | 2026-05-19 | Ratification of the selection of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026. | Against | FOR — 4 of 4 Nationwide funds | Against | Passed (calculated), 97.9% support |
| The Pennant Group, Inc. | 2026-05-14 | Election of Directors: Brent J. Guerisoli | Against | FOR — 4 of 4 Nationwide funds | Against | Elected, 82.0% support |
| The Pennant Group, Inc. | 2026-05-14 | Election of Directors: Christopher R. Christensen | Against | FOR — 4 of 4 Nationwide funds | Against | Elected, 78.3% support |
| The Pennant Group, Inc. | 2026-05-14 | Election of Directors: John G. Nackel, Ph.D. | Against | FOR — 4 of 4 Nationwide funds | Against | Elected, 78.5% support |
| A-Mark Precious Metals, Inc. | 2025-11-12 | Advisory vote on executive compensation | Against | FOR — 4 of 4 Nationwide funds | Against | Passed (calculated), 76.4% support |
| Rigel Pharmaceuticals, Inc. | 2026-05-14 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. | Against | FOR — 4 of 4 Nationwide funds | Against | Approved, 87.5% support |
| SmartFinancial, Inc. | 2026-05-21 | To approve, on a non-binding advisory basis, the compensation of SmartFinancial's named executive officers as listed in these proxy materials. | Against | FOR — 4 of 4 Nationwide funds | Against | Approved, 97.1% support |
| Cytek Biosciences, Inc. | 2026-06-10 | To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | Against | FOR — 4 of 4 Nationwide funds | Against | Approved, 99.6% support |
| Puma Biotechnology, Inc. | 2026-06-11 | Advisory (non-binding) vote to approve the compensation of Puma Biotechnology, Inc.'s named executive officers as described in the proxy statement. | Against | FOR — 4 of 4 Nationwide funds | Against | Approved, 78.8% support |
| Puma Biotechnology, Inc. | 2026-06-11 | Ratification of the selection of KPMG LLP as independent registered public accounting firm of Puma Biotechnology, Inc. for the fiscal year ending December 31, 2026. | Against | FOR — 4 of 4 Nationwide funds | Against | Approved, 97.0% support |
| Johnson Outdoors Inc. | 2026-02-26 | To approve a non-binding advisory proposal on executive compensation. | Against | FOR — 4 of 4 Nationwide funds | Against | — |
| STRATTEC Security Corporation | 2025-10-15 | Advisory Vote to Approve Executive Compensation | Against | FOR — 4 of 4 Nationwide funds | Against | Passed (calculated), 95.7% support |
| STRATTEC Security Corporation | 2025-10-15 | Ratification of Appointment of Independent Registered Public Accounting Firm | Against | FOR — 4 of 4 Nationwide funds | Against | Approved, 96.2% support |
| LiveRamp Holdings, Inc. | 2025-08-12 | Approval of an increase in the number of shares available for issuance under the Company's Amended and Restated 2005 Equity Compensation Plan. | Against | FOR — 4 of 4 Nationwide funds | Against | Approved, 75.2% support |
| Theravance Biopharma, Inc. | 2026-06-12 | Ratify the appointment of Ernst & Young LLP as Theravance Biopharma, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. | Against | FOR — 4 of 4 Nationwide funds | Against | Approved, 98.8% support |
| Vaxcyte, Inc. | 2026-06-15 | 2 wordings Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Olivier Brandicourt, M.D. | Withhold | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 87.5% support |
| Alkermes plc | 2026-05-20 | To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm's remuneration. | Against | FOR — 3 of 3 Nationwide funds | Against | — |
| Praxis Precision Medicines, Inc. | 2026-06-10 | To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrat | Against | FOR — 3 of 3 Nationwide funds | Against | Approved, 96.7% support |
| UiPath, Inc. | 2026-06-25 | To elect as directors the eight nominees named in the Company's proxy statement, each to hold office until our Annual Meeting of Stockholders in 2027: Daniel Dines | Withhold | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 98.8% support |
| UiPath, Inc. | 2026-06-25 | To elect as directors the eight nominees named in the Company's proxy statement, each to hold office until our Annual Meeting of Stockholders in 2027: June Yang | Withhold | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 98.7% support |
| Dianthus Therapeutics, Inc. | 2026-05-21 | To approve, on an advisory basis, the compensation paid to our named executive officers; and | Against | FOR — 3 of 3 Nationwide funds | Against | Approved, 96.0% support |
| Dianthus Therapeutics, Inc. | 2026-05-21 | To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorge | Withhold | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 80.6% support |
| Erasca, Inc. | 2026-06-26 | To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Alexander W. Casdin | Withhold | FOR — 3 of 3 Nationwide funds | Against | Elected, 88.0% support |
| Erasca, Inc. | 2026-06-26 | To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Julie Hambleton, M.D. | Withhold | FOR — 3 of 3 Nationwide funds | Against | Elected, 89.7% support |
| Erasca, Inc. | 2026-06-26 | To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Michael D. Varney, Ph.D. | Withhold | FOR — 3 of 3 Nationwide funds | Against | Elected, 89.7% support |
| Laureate Education, Inc. | 2026-05-21 | To elect nine (9) directors, each of whom shall hold office for a one year term until the 2027 Annual Meeting of Stockholders: Andrew B. Cohen | Withhold | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 79.3% support |
| Laureate Education, Inc. | 2026-05-21 | To elect nine (9) directors, each of whom shall hold office for a one year term until the 2027 Annual Meeting of Stockholders: Ian K. Snow | Withhold | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 75.2% support |
| M/I Homes, Inc. | 2026-05-13 | A non-binding, advisory resolution to approve the compensation of the named executive officers of M/I Homes, Inc. | Against | FOR — 3 of 3 Nationwide funds | Against | Approved, 95.7% support |
| National HealthCare Corporation | 2026-05-07 | To consider an advisory vote on the compensation of our named executive officers. | Against | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 98.1% support |
| Uranium Energy Corp. | 2025-07-17 | To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm. | Against | FOR — 3 of 3 Nationwide funds | Against | — |
| Resideo Technologies, Inc. | 2026-06-03 | Shareholder Shareholder Proposal Regarding Shareholder Right to Act by Written Consent. | For | AGAINST — 3 of 3 Nationwide funds | Against | Not approved, 23.7% support |
| IDEAYA Biosciences, Inc. | 2026-06-16 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; and | Against | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 88.5% support |
| Customers Bancorp, Inc. | 2026-05-26 | To approve a non-binding advisory resolution on named executive officer compensation. | Against | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 67.9% support |
| Customers Bancorp, Inc. | 2026-05-26 | To approve an amendment to the Company's 2019 Stock Incentive Plan. | Against | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 69.8% support |
| United Natural Foods, Inc. | 2025-12-16 | The approval of the Fifth Amended and Restated 2020 Equity Incentive Plan. | Against | FOR — 3 of 3 Nationwide funds | Against | Approved, 72.5% support |
| Flywire Corporation | 2026-06-02 | Elect three directors to serve as Class II directors until the 2029 Annual Meeting of Stockholders: Alex Finkelstein | Withhold | FOR — 3 of 3 Nationwide funds | Against | Elected, 70.3% support |
| Flywire Corporation | 2026-06-02 | Elect three directors to serve as Class II directors until the 2029 Annual Meeting of Stockholders: Gretchen Howard | Withhold | FOR — 3 of 3 Nationwide funds | Against | Elected, 74.1% support |
| Flywire Corporation | 2026-06-02 | Elect three directors to serve as Class II directors until the 2029 Annual Meeting of Stockholders: Matthew Harris | Withhold | FOR — 3 of 3 Nationwide funds | Against | Elected, 73.4% support |
| Pediatrix Medical Group, Inc. | 2026-05-07 | Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: John M. Starcher, Jr. | Against | FOR — 3 of 3 Nationwide funds | Against | Elected, 64.1% support |
| Harmony Biosciences Holdings, Inc. | 2026-05-14 | The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Ron Philip | Withhold | FOR — 3 of 3 Nationwide funds | Against | Elected, 68.5% support |
| Centuri Holdings, Inc. | 2026-05-19 | Election of Directors: Anne L. Mariucci | Withhold | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 79.5% support |
| Wolverine World Wide, Inc. | 2026-05-07 | Shareholder Shareholder proposal regarding new climate change polices or practices. | For | AGAINST — 3 of 3 Nationwide funds | Against | Not approved, 10.6% support |
| Wolverine World Wide, Inc. | 2026-05-07 | Advisory resolution to approve executive compensation. | Against | FOR — 3 of 3 Nationwide funds | Against | Approved, 96.6% support |
| Gentherm Incorporated | 2026-05-14 | Approval (on an advisory basis) of the compensation of the Company's named executive officers for the year ended December 31, 2025. | Against | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 91.6% support |
| Gentherm Incorporated | 2026-05-14 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. | Against | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 97.7% support |
| Westamerica Bancorporation | 2026-04-23 | Approve a non-binding advisory vote on the compensation of our executive officers. | Against | FOR — 5 of 6 Nationwide funds | Against | Approved, 98.0% support |
| Fresh Del Monte Produce Inc. | 2026-06-04 | Approve, by non-binding advisory vote, the compensation of our named executive officers in 2025 | Against | FOR — 3 of 3 Nationwide funds | Against | Approved, 96.3% support |
| Fresh Del Monte Produce Inc. | 2026-06-04 | Elect two director nominees for a three-year term expiring at the 2029 Annual General Meeting of Shareholders: Lori Tauber Marcus | Against | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 85.5% support |
| Fresh Del Monte Produce Inc. | 2026-06-04 | Elect two director nominees for a three-year term expiring at the 2029 Annual General Meeting of Shareholders: Michael J. Berthelot | Against | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 78.6% support |
| Nabors Industries Ltd. | 2026-06-02 | ELECTION OF DIRECTORS: Tanya S. Beder | For | WITHHOLD — 3 of 3 Nationwide funds | For | Elected, 77.7% support |
| Janux Therapeutics, Inc. | 2026-06-11 | To elect the two nominees for Class II director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Natasha Hernday | Withhold | FOR — 3 of 3 Nationwide funds | Against | Elected, 90.5% support |
| Monte Rosa Therapeutics, Inc. | 2026-06-11 | To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Anthony Manning, Ph.D. | Withhold | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 79.0% support |
| Douglas Dynamics, Inc. | 2026-04-29 | Advisory vote (non-binding) to approve the compensation of the Company's named executive officers. | Against | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 96.2% support |
| Mitek Systems, Inc. | 2026-03-03 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers as presented in the Proxy Statement accompanying this notice. | Against | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 81.4% support |
| Cytek Biosciences, Inc. | 2026-06-10 | To elect our three Class II director nominees, Vera Imper, Ph.D., Glenn P. Muir, and Ming Yan, Ph.D., each to serve a three-year term expiring at our 2029 annual meeting of stockholders and until his or her successor is duly elected and qualified, or until his or her earlier death, resignation, or r | Withhold | FOR — 3 of 3 Nationwide funds | Against | Elected, 75.8% support |
| Neurogene Inc. | 2026-06-03 | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. | Against | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 99.6% support |
| Gray Media, Inc. | 2026-05-06 | Election of Directors: Howell W. Newton | Withhold | FOR — 3 of 3 Nationwide funds | Against | Elected, 86.2% support |
| Gray Media, Inc. | 2026-05-06 | Election of Directors: Lorraine McClain | Withhold | FOR — 3 of 3 Nationwide funds | Against | Elected, 87.8% support |
| Gray Media, Inc. | 2026-05-06 | Election of Directors: Richard B. Hare | Withhold | FOR — 3 of 3 Nationwide funds | Against | Elected, 79.6% support |
| Gray Media, Inc. | 2026-05-06 | Election of Directors: Richard L. Boger | Withhold | FOR — 3 of 3 Nationwide funds | Against | Elected, 86.5% support |
| Gray Media, Inc. | 2026-05-06 | Election of Directors: Sterling A. Spainhour, Jr. | Withhold | FOR — 3 of 3 Nationwide funds | Against | Elected, 87.8% support |
| Citizens Financial Services, Inc. | 2026-04-21 | Advisory vote to approve the compensation of the Company's named executive officers as disclosed in the proxy statement. | Against | FOR — 3 of 3 Nationwide funds | Against | Approved, 82.6% support |
| Citizens Financial Services, Inc. | 2026-04-21 | Approval of the Citizens Financial Services, Inc. 2026 Equity Incentive Plan. | Against | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 82.1% support |
| Information Services Group, Inc. | 2026-04-24 | To approve, in a non-binding advisory vote, the compensation paid to the Company's named executive officers. | Against | FOR — 3 of 3 Nationwide funds | Against | Approved, 98.7% support |
| Fulcrum Therapeutics, Inc. | 2026-06-24 | Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Sonja Banks | Withhold | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 80.3% support |
| Electromed, Inc. | 2025-11-14 | To approve, on a non-binding and advisory basis, our executive compensation. | Against | FOR — 3 of 3 Nationwide funds | Against | Approved, 93.8% support |
| Niagen Bioscience, Inc. | 2026-06-24 | A nonbinding advisory vote of the Company's stockholders, as recommended by the Compensation Committee and approved by the Board, on the compensation of the Company's named executive officers disclosed in the Proxy Solicitation Materials | Against | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 95.7% support |
| Protara Therapeutics, Inc. | 2026-06-12 | Approval of an amendment to the Protara Therapeutics, Inc. 2024 Equity Incentive Plan | Against | FOR — 3 of 3 Nationwide funds | Against | Approved, 58.6% support |
| Protara Therapeutics, Inc. | 2026-06-12 | Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the proxy statement | Against | FOR — 3 of 3 Nationwide funds | Against | Approved, 94.6% support |
| Protara Therapeutics, Inc. | 2026-06-12 | Election of three Class III directors to the Board of Directors of Protara Therapeutics, Inc., each to hold office until the annual meeting of stockholders in 2029: Barry Flannelly, Pharm.D. | Withhold | FOR — 3 of 3 Nationwide funds | Against | Elected, 82.2% support |
| Protara Therapeutics, Inc. | 2026-06-12 | Election of three Class III directors to the Board of Directors of Protara Therapeutics, Inc., each to hold office until the annual meeting of stockholders in 2029: Jesse Shefferman | Withhold | FOR — 3 of 3 Nationwide funds | Against | Elected, 86.3% support |
| Nkarta, Inc. | 2026-06-10 | Advisory approval of the compensation paid to the company's named executive officers, as disclosed in the proxy statement. | Against | FOR — 3 of 3 Nationwide funds | Against | Approved, 92.9% support |
| Select Medical Holdings Corporation | 2026-04-23 | Shareholder Non-Binding Advisory Vote on a Stockholder Proposal to provide stockholders the right to call a special meeting of stockholders at a 10% ownership threshold, if properly presented at the meeting. | For | AGAINST — 3 of 3 Nationwide funds | Against | Failed (calculated), 20.0% support |
| Select Medical Holdings Corporation | 2026-04-23 | Non-Binding Advisory Vote on a Company Proposal to provide stockholders the right to call a special meeting of stockholders at a 25% ownership threshold. | Against | FOR — 3 of 3 Nationwide funds | Against | — |
| Select Medical Holdings Corporation | 2026-04-23 | Non-Binding Advisory Vote on the Compensation of Our Named Executive Officers. | Against | FOR — 3 of 3 Nationwide funds | Against | Passed (calculated), 97.1% support |
| Viant Technology Inc. | 2026-06-04 | To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | Against | FOR — 3 of 3 Nationwide funds | Against | — |
| International Bancshares Corporation | 2026-05-18 | ELECTION OF DIRECTORS: A. R. Sanchez, Jr. | For | AGAINST — 4 of 5 Nationwide funds | For | Elected, 85.9% support |
| EPAM Systems, Inc. | 2026-05-21 | To approve an amendment to the EPAM Systems, Inc. 2025 Long Term Incentive Plan to add 4,000,000 additional shares. | Against | FOR — 4 of 6 Nationwide funds | Against | Approved, 80.1% support |
| Praxis Precision Medicines, Inc. | 2026-06-10 | To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William Young | Withhold | FOR — 3 of 4 Nationwide funds | Against | Passed (calculated), 85.5% support |
| CRISPR Therapeutics AG | 2026-06-04 | Re-election of Douglas A. Treco, Ph.D. | For | AGAINST — 3 of 4 Nationwide funds | For | Elected, 91.1% support |
| Boot Barn Holdings, Inc. | 2025-08-27 | Election of Directors: Lisa G. Laube | For | WITHHOLD — 3 of 4 Nationwide funds | For | Elected, 78.3% support |
| MaxLinear, Inc. | 2026-05-20 | To approve an amendment and restatement of the MaxLinear, Inc. Amended and Restated 2010 Equity Incentive Plan, including approval of a new ten-year term and an increase in the number of shares reserved thereunder by 3,204,107. | Against | FOR — 3 of 4 Nationwide funds | Against | — |
| CareDx, Inc. | 2026-06-11 | Approval of an amendment to the 2024 Equity Incentive Plan. | Against | FOR — 3 of 4 Nationwide funds | Against | Passed (calculated), 66.8% support |
| Par Pacific Holdings, Inc. | 2026-04-30 | To approve the Par Pacific Holdings, Inc. 2026 Long-Term Incentive Plan. | Against | FOR — 4 of 6 Nationwide funds | Against | Passed (calculated), 70.6% support |
| ACM Research, Inc. | 2026-06-10 | Election of Directors: David H. Wang | Withhold | FOR — 4 of 6 Nationwide funds | Against | Elected, 95.3% support |
| ACM Research, Inc. | 2026-06-10 | Election of Directors: Tracy Liu | Withhold | FOR — 4 of 6 Nationwide funds | Against | Elected, 93.8% support |
| Ambarella, Inc. | 2026-06-26 | To approve an amendment and restatement of the Ambarella, Inc. 2021 Equity Incentive Plan. | Against | FOR — 3 of 4 Nationwide funds | Against | — |
| BioCryst Pharmaceuticals, Inc. | 2026-06-11 | To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. | Against | FOR — 3 of 4 Nationwide funds | Against | Approved, 65.4% support |
| nLIGHT, Inc. | 2026-06-05 | Election of Class II Director: Geoffrey Moore | Withhold | FOR — 3 of 4 Nationwide funds | Against | Passed (calculated), 55.6% support |
| The Pennant Group, Inc. | 2026-05-14 | Advisory approval of the Company's named executive officer compensation | Against | FOR — 3 of 4 Nationwide funds | Against | Approved, 78.4% support |
| Janux Therapeutics, Inc. | 2026-06-11 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. | Against | FOR — 3 of 4 Nationwide funds | Against | Approved, 90.3% support |
| Sphere Entertainment Co. | 2026-06-10 | Approval of, on an advisory basis, the compensation of our named executive officers. | Against | FOR — 3 of 5 Nationwide funds | Against | Passed (calculated), 94.1% support |
| BankUnited, Inc. | 2026-05-21 | To approve the BankUnited, Inc. Amended and Restated 2023 Omnibus Equity Incentive Plan. | Against | FOR — 3 of 5 Nationwide funds | Against | Passed (calculated), 60.2% support |
| ACM Research, Inc. | 2026-06-10 | Election of Directors: Charles Pappis | Withhold | FOR — 3 of 5 Nationwide funds | Against | Elected, 90.9% support |
| IDT Corporation | 2025-12-11 | Election of Directors: Elaine S. Yatzkan | Against | FOR — 3 of 5 Nationwide funds | Against | Elected, 91.4% support |
| IDT Corporation | 2025-12-11 | Election of Directors: Howard S. Jonas | Against | FOR — 3 of 5 Nationwide funds | Against | Elected, 89.8% support |
| IDT Corporation | 2025-12-11 | Election of Directors: Irwin Katsof | Against | FOR — 3 of 5 Nationwide funds | Against | Elected, 90.9% support |
| Bandwidth Inc. | 2026-05-28 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement; | Against | FOR — 3 of 5 Nationwide funds | Against | Approved, 75.5% support |
| Bandwidth Inc. | 2026-05-28 | To elect two Class III directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: David A. Morken | Withhold | FOR — 3 of 5 Nationwide funds | Against | Elected, 81.9% support |
| Bandwidth Inc. | 2026-05-28 | To elect two Class III directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Rebecca G. Bottorff | Withhold | FOR — 3 of 5 Nationwide funds | Against | Elected, 77.8% support |
| Stitch Fix, Inc. | 2025-12-11 | Election of Directors: Kofi Amoo-Gottfried | Withhold | FOR — 3 of 5 Nationwide funds | Against | Elected, 91.6% support |
| Stitch Fix, Inc. | 2025-12-11 | Election of Directors: Timothy Baxter | Withhold | FOR — 3 of 5 Nationwide funds | Against | Elected, 93.8% support |
| Designer Brands Inc. | 2026-06-17 | Amend the provisions relating to director and officer indemnification and related matters. | Against | FOR — 3 of 5 Nationwide funds | Against | Passed (calculated), 83.9% support |
| Designer Brands Inc. | 2026-06-17 | Election of Directors: Peter S. Cobb | Withhold | FOR — 3 of 5 Nationwide funds | Against | Elected, 90.0% support |
| Ranger Energy Services, Inc. | 2026-05-15 | To elect Class II directors to hold office until the 2029 Annual Meeting: Sean Woolverton | Withhold | FOR — 3 of 5 Nationwide funds | Against | Elected, 62.0% support |
| Ranger Energy Services, Inc. | 2026-05-15 | To elect Class II directors to hold office until the 2029 Annual Meeting: Stuart N. Bodden | Withhold | FOR — 3 of 5 Nationwide funds | Against | Elected, 63.7% support |
| Darling Ingredients Inc. | 2026-05-07 | To elect as directors of the Company the ten nominees named in the accompanying proxy statement to serve until the next annual meeting of stockholders: Charles Adair | For | AGAINST — 2 of 3 Nationwide funds | For | Elected, 84.3% support |
| UiPath, Inc. | 2026-06-25 | To elect as directors the eight nominees named in the Company's proxy statement, each to hold office until our Annual Meeting of Stockholders in 2027: Philippe Botteri | Withhold | FOR — 2 of 3 Nationwide funds | Against | Passed (calculated), 98.0% support |
| SSR Mining Inc. | 2026-05-07 | Election of Directors: Karen Swager | For | WITHHOLD — 2 of 3 Nationwide funds | For | Elected, 83.5% support |
| SSR Mining Inc. | 2026-05-07 | Election of Directors: Thomas R. Bates, Jr. | For | WITHHOLD — 2 of 3 Nationwide funds | For | Elected, 61.6% support |
| California Resources Corporation | 2026-04-30 | To approve, by non-binding vote, named executive officer compensation. | Against | FOR — 2 of 3 Nationwide funds | Against | Approved, 84.8% support |
| Flywire Corporation | 2026-06-02 | Approve, on a non-binding, advisory basis, the compensation of Flywire Corporation's named executive officers | Against | FOR — 2 of 3 Nationwide funds | Against | Approved, 81.6% support |
| Harmony Biosciences Holdings, Inc. | 2026-05-14 | The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Troy Ignelzi | For | WITHHOLD — 2 of 3 Nationwide funds | For | Elected, 70.6% support |
| Flowco Holdings Inc. | 2026-05-07 | The election of two Class I directors to serve until the 2029 Annual Meeting of Stockholders and until his/her successors are duly elected and qualified: Joseph R. Edwards | Withhold | FOR — 2 of 3 Nationwide funds | Against | Elected, 98.4% support |
| Rigel Pharmaceuticals, Inc. | 2026-05-14 | To approve an amendment to our 2018 Equity Incentive Plan, as amended (the "Amended 2018 Plan"), to add an additional 500,000 shares to the number of shares of common stock authorized for issuance under the Amended 2018 Plan. | Against | FOR — 2 of 3 Nationwide funds | Against | Approved, 63.0% support |
| Puma Biotechnology, Inc. | 2026-06-11 | Election of directors to serve for a one-year term: Troy E. Wilson | For | WITHHOLD — 2 of 3 Nationwide funds | For | Passed (calculated), 85.8% support |
| Viant Technology Inc. | 2026-06-04 | To elect two Class II directors, to hold office until our Annual Meeting of Stockholders in 2029 and until their successors are duly elected and qualified, or until their earlier death, resignation or removal: Chris Vanderhook | Withhold | FOR — 2 of 3 Nationwide funds | Against | — |
Download all 160 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 94.3% of this fund’s 2,340 such votes could be given a sector; the other 133 (5.7%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 458 | 6 | 1.3% |
| Finance | 442 | 0 | 0.0% |
| Health Care | 404 | 1 | 0.2% |
| Industrials | 254 | 3 | 1.2% |
| Technology | 181 | 2 | 1.1% |
| Real Estate | 165 | 0 | 0.0% |
| Utilities | 108 | 0 | 0.0% |
| Energy | 97 | 0 | 0.0% |
| Consumer Staples | 34 | 1 | 2.9% |
| Basic Materials | 28 | 0 | 0.0% |
| Telecommunications | 19 | 0 | 0.0% |
| Miscellaneous | 17 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 1,613 | 1 |
| Say-on-Pay | 283 | 2 |
| Audit-related | 260 | 0 |
| Compensation | 94 | 0 |
| Corporate Governance | 60 | 8 |
| Extraordinary Transactions | 26 | 0 |
| Capital Structure | 24 | 0 |
| Shareholder Rights and Defenses | 5 | 0 |
| Environment or Climate | 1 | 1 |
| Human Rights or Human Capital/workforce | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Par Pacific Holdings, Inc. | April 30, 2026 | $1M | 14 | 0 |
| DiamondRock Hospitality Company | April 28, 2026 | $1M | 10 | 0 |
| Tompkins Financial Corporation | May 19, 2026 | $1M | 13 | 0 |
| CBL & Associates Properties, Inc. | May 21, 2026 | $1M | 9 | 0 |
| Pediatrix Medical Group, Inc. | May 7, 2026 | $1M | 12 | 0 |
| ACI Worldwide, Inc. | June 2, 2026 | $1M | 11 | 0 |
| OUTFRONT Media Inc. | June 3, 2026 | $1M | 12 | 0 |
| Mercantile Bank Corporation | May 21, 2026 | $1M | 14 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| March 9, 2026 | Sanmina Corporation | To consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposal | For | Against |
| April 29, 2026 | BorgWarner Inc. | Vote on stockholder proposal regarding action by written consent. Shareholder proposal | Against | For |
| May 1, 2026 | Ryder System, Inc. | To vote, on an advisory basis, on a shareholder proposal regarding an independent board chair. Shareholder proposal | For | Against |
| April 22, 2026 | Dana Incorporated | Shareholder proposal to require an independent Board Chairman. Shareholder proposal | For | Against |
| May 5, 2026 | SkyWest, Inc. | A shareholder proposal regarding collective bargaining policy. Shareholder proposal | For | Against |
| June 3, 2026 | Resideo Technologies, Inc. | Shareholder Proposal Regarding Shareholder Right to Act by Written Consent. Shareholder proposal | For | Against |
| May 7, 2026 | Wolverine World Wide, Inc. | Shareholder proposal regarding new climate change polices or practices. Shareholder proposal | For | Against |
| April 30, 2026 | Ingles Markets, Incorporated | To elect two directors to serve until the Company's 2027 annual meeting of shareholders and until their successors are duly elected and qualified: SUMMER ROAD NOMINEE: Rory A. Held Shareholder proposal | For | Against |
| May 26, 2026 | El Pollo Loco Holdings, Inc. | A Shareholder Proposal requesting the Adoption of a Majority Voting Standard for the Election of Directors in Uncontested Elections. Shareholder proposal | For | Against |
| May 21, 2026 | EPAM Systems, Inc. | To hold an advisory vote on a stockholder proposal, entitled "Give Shareholders an Ability to Call for a Special Shareholder Meeting." Shareholder proposal | For | Against |
| May 21, 2026 | Constellium SE | Advisory (non-binding) vote to hold an advisory (non-binding vote) on the compensation of the Company's named executive officers every two years | Against | For |
| May 21, 2026 | Constellium SE | Advisory (non-binding) vote to hold an advisory (non-binding vote) on the compensation of the Company's named executive officers every three years | Against | For |
Meetings with a proxy contest or competing nominees (2 in 2025-2026), and how the fund voted the items on its ballot.
2,368 ballot items at 283 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Nationwide Bailard Cognitive Value Fund (NWHDX) voted at 283 shareholder meetings of 279 companies, on 2,368 ballot items in all. Where management made a recommendation, the fund followed it on 99.4% of the items and voted against it 13 times. Its most frequent area of disagreement was corporate governance (8 of its votes against management). It voted on 11 shareholder proposals. It voted FOR the board's own proposals less often than Nationwide's funds as a whole (85.7% against 94.0%). It voted differently from most Nationwide funds on 160 items. 2 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Nationwide’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.